|
IRB Warned for Missing Operating Procedures, Records
The FDA has warned a New York-based IRB for failing to have any written procedures describing the ethics committee’s functions and a lack of key documentation, including copies of reviewed research proposals and approved consent forms.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives